Open an Account
search icon
1
NOTIFICATIONS
Best Algo trading app in India
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 With reference to the captioned subject, please find enclosed herewith the intimations dated 24th April, 2023 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request/application from the registered shareholder(s) of the Company for i) issue of Duplicate Share Certificate(s) and ii) issue of Duplicate Share Certificate(s) for the purpose of claiming the shares from the Investor Education and Protection Fund (IEPF).
24-04-2023
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Board Meeting Intimation for Board Meeting To Consider Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2023

 ALEMBIC PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2023 ,inter alia, to consider and approve 1. Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2023. 2. Dividend on equity shares, if any, for the financial year ended 31st March, 2023. Pursuant to the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in securities of the Company which was closed from 1st April, 2023, will re-open 48 hours after the declaration of the financial results.
24-04-2023
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 With reference to the captioned subject, please find enclosed herewith the intimations dated 22nd April, 2023 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).
22-04-2023
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 In view of the various recent regulatory developments, including SEBI's press release dated 29th March, 2023 read with SEBI's Consultation Paper dated 12th November, 2022 to revise the disclosure requirements for material events, the persons authorized under the Company's Materiality Policy have decided to change the practice followed by the Company for making disclosures for product approvals and henceforth provide disclosures for only such product approvals which fall within the purview of the statutory requirements.
17-04-2023
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2023

 With reference to the captioned subject, we enclose herewith Certificate under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the financial year ended 31st March, 2023, issued by M/s. Samdani Shah & Kabra, Practising Company Secretaries, Vadodara.
10-04-2023
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 With reference to the captioned matter, please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2023, received from M/s. Link lntime India Private Limited, Registrar and Share Transfer Agent of our Company.
07-04-2023
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliance Certificate Pursuant To Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March, 2023

 With reference to the captioned subject, we hereby confirm that all activities in relation to both physical and electronic share transfer facility are maintained by the Company's Registrar and Share Transfer Agent viz. Link Intime India Private Limited, which is a SEBI approved Category-I Registrar & Transfer Agent, registered with the Securities and Exchange Board of India (SEBI Registration Number: INR000004058).
07-04-2023
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 With reference to the captioned subject, please find enclosed herewith the intimations dated 5th April, 2023 received from Link lntime India Private Limited, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).
05-04-2023
Bigul

ALEMBIC PHARMACEUTICALS LTD. - 533573 - Closure of Trading Window

 With reference to the captioned matter, this is to inform the exchange that in terms of the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives framed pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company will remain closed from 1st April, 2023 till 48 hours after the declaration of the audited financial results for the quarter and financial year ended 31st March, 2023. The date of the Board Meeting for inter alia considering the audited financial results for the quarter and financial year ended 31st March, 2023 will be intimated in due course.
31-03-2023

Alembic Pharma shares up 5% on USFDA approval for glaucoma drug

 Alembic Pharmaceuticals' share touched a 52-week high of Rs 792.30 on April 28, 2022 and a 52-week low of Rs 463.30 on March 29
31-03-2023
Next Page
Close

Let's Open Free Demat Account